Susan Palmer
Family · Grand Island, NENPI 1497396923
Payments from drug & device makers
Across 163 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$882
- Otsuka America Pharmaceutical, Inc.$449
- Medtronic$331
- Biohaven Pharmaceutical Holding Company Ltd.$155
- Takeda Pharmaceuticals U.S.A., Inc.$75
- Teva Pharmaceuticals USA, Inc.$58
- plus $470 from 18 others
What the payments were for
- Food & beverage$2,420100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,420 in reported general payments places this provider in the 85th percentile of 809 family providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $16,874 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,446 |
| Lurasidone Hcl | 26 | $2,190 |
| Aripiprazole | 34 | $1,259 |
| Divalproex Sodium | 12 | $761 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $756 |
| Gabapentin | 17 | $749 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 49 | $575 |
| Risperidone | 16 | $435 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $423 |
| Prazosin Hcl | 18 | $236 |
| Lamotrigine | 41 | $208 |
| Buspirone Hcl | 26 | $196 |
| Hydroxyzine Hcl | 15 | $179 |
| Bupropion XlBupropion Hcl | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $882 | $16,87412 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $75 | $6,44613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 809 family providers in Nebraska.
Other family in Grand Island
- Mark HarveyGrand Island$4K
- Chantel CollierFriend$257K
- Stephanie SimonOmaha$157K
- Rebecca NewberryOmaha$156K
- Michelle BrtekzwienerNorfolk$59K
- Angela CraigOmaha$35K
- Laura FalconeOmaha$26K
- Ladeana SmedlundBoys Town$21K
- Brittany MatneyOmaha$14K
- Patricia TeeterWahoo$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.